Kamada (KMDA) Inventory Average (2012 - 2026)
Kamada (KMDA) posted quarterly Inventory Average of $85.2 million for Q1 2026, up 8.4% year-on-year from $78.6 million in Q1 2025, and little changed on a QoQ basis from $85.2 million in Q4 2025.
Kamada (KMDA) Inventory Average (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Inventory Average for 15 consecutive years, with $85.2 million the latest figure, recorded in Q1 2026.
- Quarterly Inventory Average rose 8.4% year-over-year to $85.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $85.2 million (up 8.4% YoY) and the FY2025 annual result came in at $81.9 million, down 2.11% from the prior year.
- Inventory Average held at $85.2 million in Q1 2026 per KMDA's latest filing, from $85.2 million in the prior quarter.
- Over the last five years, Inventory Average for KMDA reached as high as $86.4 million in Q1 2024 and fell as low as $32.3 million in Q3 2022.
- A 5-year average of $68.3 million and a median of $77.0 million in 2023 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2023 — Inventory Average tumbled 47.9% — and 2024, when it soared 150.97%.
- Year by year, Inventory Average stood at $34.4 million in 2022, then jumped by 135.66% to $81.1 million in 2023, then slipped by 7.33% to $75.2 million in 2024, then climbed by 13.29% to $85.2 million in 2025, then rose by 0.01% to $85.2 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $85.2 million, $85.2 million, and $83.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 9.02 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 180.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.11 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.96 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 66.75 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.73 Bn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | 85.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 85.19 Mn |
| Dec 31, 2025 | 85.18 Mn |
| Sep 30, 2025 | 83.75 Mn |
| Jun 30, 2025 | 80.22 Mn |
| Mar 31, 2025 | 78.59 Mn |
| Dec 31, 2024 | 75.19 Mn |
| Sep 30, 2024 | 75.14 Mn |
| Jun 30, 2024 | 81.53 Mn |
| Mar 31, 2024 | 86.41 Mn |
| Dec 31, 2023 | 81.14 Mn |
| Sep 30, 2023 | 77.02 Mn |
| Jun 30, 2023 | 40.16 Mn |
| Mar 31, 2023 | 34.43 Mn |
| Dec 31, 2022 | 34.43 Mn |
| Sep 30, 2022 | 32.30 Mn |
| Jun 30, 2022 | 64.64 Mn |
| Mar 31, 2022 | 66.09 Mn |
| Dec 31, 2021 | 57.79 Mn |
| Sep 30, 2021 | 46.38 Mn |
| Jun 30, 2021 | 42.88 Mn |